Previous studies suggest that klotho function and dysregulation of the FGF23-klotho pathway, causing hyperphosphatemia and endothelial dysfunction, are associated with the pathogenic mechanisms of CKD development and disease progression (21, 22, 27). Here, FGF23 is linked to hyperphosphatemia.